MedTrace Logo

Stimulation Parameters and Non-motor Symptoms in PD Treated With DBS

NCT03800108 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-02-05

Study results available
· View outcomes & findings →

Summary

This study evaluates the role of subthalamic nucleus (STN) stimulation location and frequency on a range of cognitive processes in Parkinson's patients who have undergone Deep Brain Stimulation (DBS).

Conditions

  • Parkinson Disease

Interventions

PROCEDURE

Personalized DBS adjustments

Individualized stimulation adjustments based on pre- and post- DBS implantation MRIs

Sponsors & Collaborators

  • Darlene Floden

    lead OTHER

Principal Investigators

  • Darlene Floden, PhD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-30
Primary Completion
2020-01-14
Completion
2020-01-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800108 on ClinicalTrials.gov